JAMP PERINDOPRIL ERBUMINE DIN 02527219
Health Canada record
| Active ingredient(s) | PERINDOPRIL ERBUMINE 4 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C09AA04 PERINDOPRIL |
| Original market date | 15-Dec-2022 |
| Current status date | 15-Dec-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PERINDOPRIL ERBUMINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02447991 | AG-PERINDOPRIL / INDAPAMIDE | ANGITA PHARMA INC. | Tablet | PERINDOPRIL ERBUMINE 2 MG; INDAPAMIDE 0.625 MG | Marketed |
| 02448017 | AG-PERINDOPRIL / INDAPAMIDE | ANGITA PHARMA INC. | Tablet | PERINDOPRIL ERBUMINE 8 MG; INDAPAMIDE 2.5 MG | Marketed |
| 02448009 | AG-PERINDOPRIL / INDAPAMIDE | ANGITA PHARMA INC. | Tablet | PERINDOPRIL ERBUMINE 4 MG; INDAPAMIDE 1.25 MG | Marketed |
| 02289296 | APO-PERINDOPRIL | APOTEX INC | Tablet | PERINDOPRIL ERBUMINE 8 MG | Marketed |
| 02289261 | APO-PERINDOPRIL | APOTEX INC | Tablet | PERINDOPRIL ERBUMINE 2 MG | Marketed |
| 02289288 | APO-PERINDOPRIL | APOTEX INC | Tablet | PERINDOPRIL ERBUMINE 4 MG | Marketed |
| 02297574 | APO-PERINDOPRIL-INDAPAMIDE | APOTEX INC | Tablet | PERINDOPRIL ERBUMINE 4 MG; INDAPAMIDE 1.25 MG | Marketed |
| 02453061 | APO-PERINDOPRIL-INDAPAMIDE | APOTEX INC | Tablet | PERINDOPRIL ERBUMINE 8 MG; INDAPAMIDE 2.5 MG | Marketed |
| 02453053 | APO-PERINDOPRIL-INDAPAMIDE | APOTEX INC | Tablet | PERINDOPRIL ERBUMINE 2 MG; INDAPAMIDE 0.625 MG | Approved |
| 02459833 | AURO-PERINDOPRIL | AURO PHARMA INC | Tablet | PERINDOPRIL ERBUMINE 8 MG | Marketed |
| 02459817 | AURO-PERINDOPRIL | AURO PHARMA INC | Tablet | PERINDOPRIL ERBUMINE 2 MG | Marketed |
| 02459825 | AURO-PERINDOPRIL | AURO PHARMA INC | Tablet | PERINDOPRIL ERBUMINE 4 MG | Marketed |
| 02246624 | COVERSYL | SERVIER CANADA INC | Tablet | PERINDOPRIL ERBUMINE 8 MG | Marketed |
| 02123274 | COVERSYL | SERVIER CANADA INC | Tablet | PERINDOPRIL ERBUMINE 2 MG | Marketed |
| 02123282 | COVERSYL | SERVIER CANADA INC | Tablet | PERINDOPRIL ERBUMINE 4 MG | Marketed |
| 02246569 | COVERSYL PLUS | SERVIER CANADA INC | Tablet | PERINDOPRIL ERBUMINE 4 MG; INDAPAMIDE 1.25 MG | Marketed |
| 02321653 | COVERSYL PLUS HD | SERVIER CANADA INC | Tablet | PERINDOPRIL ERBUMINE 8 MG; INDAPAMIDE 2.5 MG | Marketed |
| 02246568 | COVERSYL PLUS LD | SERVIER CANADA INC | Tablet | PERINDOPRIL ERBUMINE 2 MG; INDAPAMIDE 0.625 MG | Marketed |
| 02474824 | MAR-PERINDOPRIL | MARCAN PHARMACEUTICALS INC | Tablet | PERINDOPRIL ERBUMINE 2 MG | Marketed |
| 02474832 | MAR-PERINDOPRIL | MARCAN PHARMACEUTICALS INC | Tablet | PERINDOPRIL ERBUMINE 4 MG | Marketed |
| 02474840 | MAR-PERINDOPRIL | MARCAN PHARMACEUTICALS INC | Tablet | PERINDOPRIL ERBUMINE 8 MG | Marketed |
| 02476789 | MINT-PERINDOPRIL | MINT PHARMACEUTICALS INC | Tablet | PERINDOPRIL ERBUMINE 8 MG | Marketed |
| 02476762 | MINT-PERINDOPRIL | MINT PHARMACEUTICALS INC | Tablet | PERINDOPRIL ERBUMINE 2 MG | Marketed |
| 02476770 | MINT-PERINDOPRIL | MINT PHARMACEUTICALS INC | Tablet | PERINDOPRIL ERBUMINE 4 MG | Marketed |
| 02481650 | PERINDOPRIL ERBUMINE | SANIS HEALTH INC | Tablet | PERINDOPRIL ERBUMINE 8 MG | Marketed |
| 02479877 | PERINDOPRIL ERBUMINE | SIVEM PHARMACEUTICALS ULC | Tablet | PERINDOPRIL ERBUMINE 2 MG | Marketed |
| 02479885 | PERINDOPRIL ERBUMINE | SIVEM PHARMACEUTICALS ULC | Tablet | PERINDOPRIL ERBUMINE 4 MG | Marketed |
| 02479893 | PERINDOPRIL ERBUMINE | SIVEM PHARMACEUTICALS ULC | Tablet | PERINDOPRIL ERBUMINE 8 MG | Marketed |
| 02481634 | PERINDOPRIL ERBUMINE | SANIS HEALTH INC | Tablet | PERINDOPRIL ERBUMINE 2 MG | Marketed |
| 02481642 | PERINDOPRIL ERBUMINE | SANIS HEALTH INC | Tablet | PERINDOPRIL ERBUMINE 4 MG | Marketed |
| 02479834 | PERINDOPRIL ERBUMINE/ INDAPAMIDE | SIVEM PHARMACEUTICALS ULC | Tablet | PERINDOPRIL ERBUMINE 4 MG; INDAPAMIDE 1.25 MG | Marketed |
| 02479842 | PERINDOPRIL ERBUMINE/ INDAPAMIDE HD | SIVEM PHARMACEUTICALS ULC | Tablet | PERINDOPRIL ERBUMINE 8 MG; INDAPAMIDE 2.5 MG | Marketed |
| 02470683 | PMS-PERINDOPRIL | PHARMASCIENCE INC | Tablet | PERINDOPRIL ERBUMINE 4 MG | Marketed |
| 02470691 | PMS-PERINDOPRIL | PHARMASCIENCE INC | Tablet | PERINDOPRIL ERBUMINE 8 MG | Marketed |
| 02470675 | PMS-PERINDOPRIL | PHARMASCIENCE INC | Tablet | PERINDOPRIL ERBUMINE 2 MG | Marketed |
| 02472031 | RIVA-PERINDOPRIL | LABORATOIRE RIVA INC. | Tablet | PERINDOPRIL ERBUMINE 8 MG | Marketed |
| 02472023 | RIVA-PERINDOPRIL | LABORATOIRE RIVA INC. | Tablet | PERINDOPRIL ERBUMINE 4 MG | Marketed |
| 02472015 | RIVA-PERINDOPRIL | LABORATOIRE RIVA INC. | Tablet | PERINDOPRIL ERBUMINE 2 MG | Marketed |
| 02470225 | SANDOZ PERINDOPRIL ERBUMINE | SANDOZ CANADA INCORPORATED | Tablet | PERINDOPRIL ERBUMINE 2 MG | Marketed |
| 02470241 | SANDOZ PERINDOPRIL ERBUMINE | SANDOZ CANADA INCORPORATED | Tablet | PERINDOPRIL ERBUMINE 8 MG | Marketed |
| 02470233 | SANDOZ PERINDOPRIL ERBUMINE | SANDOZ CANADA INCORPORATED | Tablet | PERINDOPRIL ERBUMINE 4 MG | Marketed |
| 02470438 | SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE | SANDOZ CANADA INCORPORATED | Tablet | PERINDOPRIL ERBUMINE 4 MG; INDAPAMIDE 1.25 MG | Marketed |
| 02470446 | SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE HD | SANDOZ CANADA INCORPORATED | Tablet | PERINDOPRIL ERBUMINE 8 MG; INDAPAMIDE 2.5 MG | Marketed |
| 02470411 | SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE LD | SANDOZ CANADA INCORPORATED | Tablet | PERINDOPRIL ERBUMINE 2 MG; INDAPAMIDE 0.625 MG | Marketed |
| 02465000 | TEVA-PERINDOPRIL | TEVA CANADA LIMITED | Tablet | PERINDOPRIL ERBUMINE 8 MG | Marketed |
| 02464985 | TEVA-PERINDOPRIL | TEVA CANADA LIMITED | Tablet | PERINDOPRIL ERBUMINE 2 MG | Marketed |
| 02464993 | TEVA-PERINDOPRIL | TEVA CANADA LIMITED | Tablet | PERINDOPRIL ERBUMINE 4 MG | Marketed |
| 02464020 | TEVA-PERINDOPRIL/INDAPAMIDE | TEVA CANADA LIMITED | Tablet | PERINDOPRIL ERBUMINE 4 MG; INDAPAMIDE 1.25 MG | Marketed |
| 02464039 | TEVA-PERINDOPRIL/INDAPAMIDE | TEVA CANADA LIMITED | Tablet | PERINDOPRIL ERBUMINE 8 MG; INDAPAMIDE 2.5 MG | Marketed |
| 02456907 | COVERSYL PLUS | SERVIER CANADA INC | Tablet | PERINDOPRIL ERBUMINE 8 MG; INDAPAMIDE 1.25 MG | Cancelled Pre Market |
| 02477009 | JAMP PERINDOPRIL | JAMP PHARMA CORPORATION | Tablet | PERINDOPRIL ERBUMINE 2 MG | Dormant |
| 02477017 | JAMP PERINDOPRIL | JAMP PHARMA CORPORATION | Tablet | PERINDOPRIL ERBUMINE 4 MG | Dormant |
| 02477025 | JAMP PERINDOPRIL | JAMP PHARMA CORPORATION | Tablet | PERINDOPRIL ERBUMINE 8 MG | Dormant |
| 02400073 | MYLAN-PERINDOPRIL ERBUMINE | MYLAN PHARMACEUTICALS ULC | Tablet | PERINDOPRIL ERBUMINE 8 MG | Cancelled Pre Market |
| 02400065 | MYLAN-PERINDOPRIL ERBUMINE | MYLAN PHARMACEUTICALS ULC | Tablet | PERINDOPRIL ERBUMINE 4 MG | Cancelled Pre Market |
| 02400057 | MYLAN-PERINDOPRIL ERBUMINE | MYLAN PHARMACEUTICALS ULC | Tablet | PERINDOPRIL ERBUMINE 2 MG | Cancelled Pre Market |
| 02408201 | MYLAN-PERINDOPRIL/INDAPAMIDE | MYLAN PHARMACEUTICALS ULC | Tablet | PERINDOPRIL ERBUMINE 8 MG; INDAPAMIDE 2.5 MG | Cancelled Pre Market |
| 02408198 | MYLAN-PERINDOPRIL/INDAPAMIDE | MYLAN PHARMACEUTICALS ULC | Tablet | PERINDOPRIL ERBUMINE 4 MG; INDAPAMIDE 1.25 MG | Cancelled Pre Market |
| 02408171 | MYLAN-PERINDOPRIL/INDAPAMIDE | MYLAN PHARMACEUTICALS ULC | Tablet | PERINDOPRIL ERBUMINE 2 MG; INDAPAMIDE 0.625 MG | Cancelled Pre Market |
| 02464012 | TEVA-PERINDOPRIL/INDAPAMIDE | TEVA CANADA LIMITED | Tablet | PERINDOPRIL ERBUMINE 2 MG; INDAPAMIDE 0.625 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 28483 | 2022-06-28 | Abbreviated New Drug Submission (ANDS) | Administrative: Change in Product Ownership |
| 28116 | 2022-05-10 | Abbreviated New Drug Submission (ANDS) |
International API supply for PERINDOPRIL ERBUMINE
3 active FDA Drug Master Files.
Request a quote for JAMP PERINDOPRIL ERBUMINE